IL-6 blockade inhibited the NMO-IgG-induced BBB dysfunction, leading to prevention of onset of NMOSD

Yukio Takeshita

Presentation information

Oral Session

[O-05] Oral Session 05 Neuroscience1

Wed. May 19, 2021 4:30 PM - 6:00 PM Room 08 (ICC Kyoto 1F Room E)

Chair：Miyamoto Katsuichi(Department of Neurology, Kindai Univercity School of Medicine),Matsushita Takuya(Department of Neurology, Kyushu University Hospital)

[O-05-2] IL-6 blockade inhibited the NMO-IgG-induced BBB dysfunction, leading to prevention of onset of NMOSD

^○Yukio Takeshita¹, Susumu Fujikawa¹, Kenichi Serizawa², Miwako Fujisawa¹, Kinya Matsuo¹, Fumitaka Shimizu¹, Yasuteru Sano¹, Michiaki Koga¹, Richard M Ransohoff³, Takashi Kanda¹ (1.Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan, 2.Product Research Department, Chugai Pharmaceutical Co., Ltd, 3.Third Rock Ventures)

Abstract password authentication.
Password is written on a pocket program and name badge.